Patents Assigned to ORBIT BIOMEDICAL LIMITED
-
Patent number: 10646374Abstract: An apparatus includes an injector, a first fluid conduit, a second fluid line, and a control module. The injector includes a body, a flexible cannula, a flexible needle, and a sensor. The needle is configured to translate relative to the cannula. The sensor is operable to detect a position of the needle relative to the cannula. The first and second fluid lines are coupled with the needle. The control module is in communication with the sensor, with the first fluid conduit, and with the second fluid conduit. The control module is configured to provide delivery of a first fluid through the first conduit to the needle based on a signal from the sensor. The control module is further configured to provide delivery of a second fluid through the second conduit to the needle.Type: GrantFiled: May 31, 2017Date of Patent: May 12, 2020Assignee: ORBIT BIOMEDICAL LIMITEDInventors: Daniel W. Price, Brendan J. Oberkircher, Daniel J. Prenger, Geoffrey King, Thomas E. Meyer, Benjamin L. Ko
-
Patent number: 10639193Abstract: An apparatus has a first fluid conduit, a second fluid conduit, a connector member, an first tubular member, a second tubular member, and an inner cannula. The connector member has first and second passageways in which the first and second fluid conduits are positioned, respectively. A portion of the second tubular member is positioned within the lumen of the first tubular member. A proximal portion of the inner cannula is fixedly secured within the lumen of the first tubular member. The inner cannula lumen is in fluid communication with the first and second fluid conduits via the lumen of the first tubular member and the lumen of the second tubular member. The inner cannula may be inserted into the subretinal space of a human eye to deliver a leading bleb of fluid and then deliver a therapeutic agent, without having to withdraw the inner cannula from the subretinal space between the acts of delivering the leading bleb delivering the therapeutic agent.Type: GrantFiled: March 19, 2018Date of Patent: May 5, 2020Assignee: ORBIT BIOMEDICAL LIMITEDInventors: Joseph H. Contiliano, Thomas E. Meyer, Daniel J. Abbott, Michael F. Keane, Allen C. Ho, Mark C. Tsai, Isaac J. Khan
-
Patent number: 10478553Abstract: An apparatus includes a body, a cannula, and a needle. The cannula is flexible and extends distally from the body. The needle is slidably disposed in the cannula. The needle includes a sharp distal tip and a curved portion. The needle is configured to translate relative to the cannula between a proximal position and a distal position. The distal tip is configured to be positioned inside the cannula when the needle is in the proximal position. The distal tip is configured to be positioned outside the cannula when the needle is in the distal position. The needle is resiliently biased to extend along a curve through the curved portion.Type: GrantFiled: February 22, 2017Date of Patent: November 19, 2019Assignee: ORBIT BIOMEDICAL LIMITEDInventors: Thomas E. Meyer, Benjamin L. Ko, Isaac J. Khan, Daniel W. Price, Brendan J. Oberkircher, Michael F. Keane
-
Patent number: 10322028Abstract: An apparatus for delivering therapeutic agent to an eye comprises a body, a cannula, a hollow needle, an actuation assembly, and a detection/visualization system. The cannula extends distally from the body and is sized and configured to be insertable between a choroid and a sclera of a patient's eye. The actuation assembly is operable to actuate the needle relative to the cannula to thereby drive a distal portion of the needle along an exit axis. The cannula may be inserted through a sclerotomy incision and advanced through the choroid to deliver the therapeutic agent adjacent to the potential space between the neurosensory retina and the retinal pigment epithelium layer. The detection/visualization system is operable to detect or visualize penetration of the choroid of a patient's eye and provide feedback to the operator and/or automatic control of the apparatus based on penetration of the choroid.Type: GrantFiled: September 1, 2015Date of Patent: June 18, 2019Assignee: ORBIT BIOMEDICAL LIMITEDInventors: Daniel W. Price, Brendan J. Oberkircher, Saeed Sokhanvar, Daniel J. Yasevac, Michel Bruehwiler, Leah R. Soffer, Gregory W. Johnson, William D. Dannaher, Stefan Troller, Urban Schnell, Jean Christophe Roulet, Alain Saurer, Michael F. Keane
-
Patent number: 10258502Abstract: A system for storing and delivering a predetermined amount of fluid includes a syringe including a barrel, a flange disposed at the proximal end of the barrel, and a plunger assembly configured to be received in the lumen of the barrel. The plunger assembly includes a piston and a plunger rod. The plunger rod is removably couplable to the piston at the distal end of the plunger rod and includes a thumb press flange at the proximal end of the plunger rod. The system further includes a stop feature that is removably couplable to the syringe or the plunger assembly. The stop feature is configured to arrest distal advancement of the plunger assembly relative to the syringe when the plunger assembly reaches a predetermined position relative to the syringe. The stop thus ensures that a predetermined amount of fluid remains in the barrel.Type: GrantFiled: September 2, 2015Date of Patent: April 16, 2019Assignee: ORBIT BIOMEDICAL LIMITEDInventors: Mark C. Tsai, Brian M. Gatton, Jr., Michael F. Keane, Isaac J. Khan, Brendan J. Oberkircher, Daniel W. Price
-
Patent number: 10245212Abstract: A packaging apparatus is provided for holding a sterile product. In one aspect, a secondary packaging holder is configured with a base and a receiving portion to receive and irreversibly hold a primary packaging holder. The secondary packaging holder can have a substantially planar wall configured to affix an identifying label thereto. The secondary packaging holder can be configured to snap fit to a neck of the primary packaging holder to hold the primary packaging holder such that a portion of the primary packaging holder is exposed outside of the secondary packaging holder based on a height relationship between the secondary packaging holder and the primary packaging holder.Type: GrantFiled: December 18, 2015Date of Patent: April 2, 2019Assignee: Orbit Biomedical LimitedInventors: Chaley Larson, Kostadinka Lilova, Mike Cannamela, William Cagney, Gordon Kosovan, Elaine Hughes, Maria Ficchi
-
Patent number: 10226379Abstract: An apparatus for delivering therapeutic agent to an eye includes a body, a cannula, a hollow needle, and an actuation assembly. The cannula extends distally from the body and is sized and configured to be insertable between a choroid and a sclera of a patient's eye. The actuation assembly is operable to actuate the needle relative to the cannula to thereby drive a distal portion of the needle along an exit axis that is obliquely oriented relative to the longitudinal axis of the cannula. The cannula may be inserted through a sclerotomy incision to position a distal end of the cannula at a posterior region of the eye, between the choroid and sclera. The needle may be advanced through the choroid to deliver the therapeutic agent adjacent to the potential space between the neurosensory retina and the retinal pigment epithelium layer, adjacent to the area of geographic atrophy.Type: GrantFiled: February 11, 2015Date of Patent: March 12, 2019Assignee: ORBIT BIOMEDICAL LIMITEDInventors: Brendan J. Oberkircher, Daniel W. Price, Michael F. Keane, Saeed Sokhanvar, Daniel J. Yasevac, Michel G. Bruehwiler, Leah R. Soffer, Isaac J. Khan, Benjamin L. Ko, Christopher D. Riemann, Nathan D. Grubbs
-
Patent number: 10219936Abstract: An apparatus for delivering therapeutic agent to an eye comprises a body, a cannula, a hollow needle, a cannula actuation assembly, and a needle actuation assembly. The cannula extends distally from the body and is sized and configured to be insertable between a choroid and a sclera of a patient's eye. The cannula actuation assembly is operable to actuate the cannula relative to the body. The needle actuation assembly is operable to actuate the needle relative to the cannula. The cannula may be inserted through a sclerotomy to position a distal end of the cannula at a posterior region of the eye, between the choroid and sclera. The needle may be advanced through the choroid to deliver the therapeutic agent adjacent to the potential space between the neurosensory retina and the retinal pigment epithelium layer, adjacent to the area of geographic atrophy.Type: GrantFiled: August 31, 2015Date of Patent: March 5, 2019Assignee: ORBIT BIOMEDICAL LIMITEDInventors: Benjamin L. Ko, Robert H. Roth, Thomas E. Meyer, Paul D. Gordon, Isaac J. Khan, Daniel W. Price, Brendan J. Oberkircher
-
Patent number: 10206852Abstract: A packaging system is provided for securely and irreversibly holding a sterile product. The packaging system includes a primary packaging holder and a secondary packaging holder. The secondary packaging holder has a body made up of a top having a receiving portion configured to receive the primary packaging holder, a base having a plurality of apertures and a first and second planar wall extending from opposing ends of the base in parallel to opposing ends of the top. The secondary packaging holder also has a first and second plate configured to secure opposing ends of an opening though the body. The first plate comprises a first securing feature, and the second plate comprises a second securing feature. The first and second securing features are capable of jointly securing and irreversibly holding the primary packaging holder in the secondary packaging holder.Type: GrantFiled: December 15, 2016Date of Patent: February 19, 2019Assignee: ORBIT BIOMEDICAL LIMITEDInventors: Chaley J. Larson, Kostadinka Lilova, Michael Cannamela, William H. Cagney, Gordon Kosovan, Elaine Hughes, Maria Ficchi
-
Patent number: 10064752Abstract: An apparatus for delivering therapeutic agent to an eye comprises a body, a cannula, a hollow needle, and an automated actuation assembly. The cannula extends distally from the body and is sized and configured to be insertable between a choroid and a sclera of a patient's eye. The actuation assembly is operable to actuate the needle relative to the cannula to thereby drive a distal portion of the needle along an exit axis that is obliquely oriented relative to the longitudinal axis of the cannula. The cannula may be inserted through a sclerotomy to position a distal end of the cannula at a posterior region of the eye, between the choroid and sclera. The needle may be advanced through the choroid to deliver the therapeutic agent adjacent to the potential space between the neurosensory retina and the retinal pigment epithelium layer, adjacent to the area of geographic atrophy.Type: GrantFiled: August 31, 2015Date of Patent: September 4, 2018Assignee: ORBIT BIOMEDICAL LIMITEDInventors: Daniel W. Price, Isaac J. Khan, Brendan J. Oberkircher, Saeed Sokhanvar, Daniel J. Yasevac, Michel Bruehwiler, Leah R. Soffer, Mohammadreza Ramerzanifard, Mary Carter
-
Patent number: D886597Type: GrantFiled: September 19, 2018Date of Patent: June 9, 2020Assignee: ORBIT BIOMEDICAL LIMITEDInventors: Chaley J. Larson, Michael Cannamela, William H. Cagney, Gordon Kosovan, Elaine Hughes, Maria Ficchi, Kostadinka Lilova
-
Patent number: D886598Type: GrantFiled: September 19, 2018Date of Patent: June 9, 2020Assignee: ORBIT BIOMEDICAL LIMITEDInventors: Chaley J. Larson, Michael Cannamela, William H. Cagney, Gordon Kosovan, Elaine Hughes, Maria Ficchi, Kostadinka Lilova